About Tg Therapeutics (TGTX)
TG Therapeutics, Inc. is a commercial-stage biopharmaceutical company that is focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The Company’s two programs in Phase III ... Read more
- USD13.87
- USD14.02
- USD13.26
- USD35.67
- -10.10%
- 234M
- 3.67M
- 2.50M
- 2.2B
- 6.46
- -37.10%
Stock News
1 hour ago
Reed Hastings shares the 3-word tactic that helped make Netflix a $240 billion company—it's called 'farming for dissent'
CNBC
1 hour ago
S&P 500 Giants, Leading AI Play Among 5 Stocks To Watch In Tough Market
Yahoo
2 hours ago
If you’re investing in the AI theme for the long haul, here’s how to pick the winners
CNBC
2 hours ago
Why the oil market shrugged as Iran and Israel appeared on the brink of war this week
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
